Company Long-Term Loans and Borrowings: Tonix Pharmaceuticals Inc. (TNXP)

Public company logo of Tonix Pharmaceuticals Inc. (TNXP)

Tonix Pharmaceuticals (TNXP) manages a portfolio of anti-infective and pain management agents, leveraging the adaptation of legacy formulas for new niches. The market dynamics reflected in the price action on GURU.Markets show the 0.00 indicator. Tonix Pharmaceuticals (TNXP) relies on the development of CNS drugs, where patent protection ensures sustained interest in chronic disease therapies. The business is currently undergoing a rigorous restructuring, concentrating capital on final-stage trials to maintain solvency.

TNXP Tonix Pharmaceuticals Company Long-Term Debts (07/04/2022 - 10/31/2026)

Summary analytical data breakdowns for Tonix Pharmaceuticals Inc. (TNXP)

- market price and analyst price targets:
Stock Price tonixpharma.com|TNXP - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Tonix Pharmaceuticals|TNXP - Total Company Value
- book capitalization information:
Accounting Value per Share Tonix Pharmaceuticals|TNXP - Book Capitalization|Market Capitalization to Book Value Ratio tonixpharma.com|TNXP - Cumulative Company Assets
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio Tonix Pharmaceuticals|TNXP - Long-Term Debt to Equity|Current Liabilities to Capital Tonix Pharmaceuticals Holding|TNXP - Company Total Debt|Debt to Book Capital Tonix Pharmaceuticals|TNXP - Company Long-Term Debts|Company Short-Term Loans and Borrowings Tonix Pharmaceuticals|Immediate Liquidity tonixpharma.com
- earnings and multiples data:
TNXP - Company Net Income
Fundamental company valuation:tonixpharma.com TNXP
Brand item of Tonix Pharmaceuticals Holding Corp.

This indicator reflects the obligations of Tonix Pharmaceuticals (TNXP) with maturities exceeding twelve months, which depend on credit policy and market rates. In fundamental analysis, this metric measures the level of long-term financial burden and the extent of the business's reliance on borrowed capital. By analyzing the company's long-term debt structure, an investor assesses the risk of macroeconomic sensitivity. For Tonix Pharmaceuticals (TNXP), such loans are critical for financing capital-intensive R&D projects in the fields of neurobiology and vaccination.

Who Tonix Pharmaceuticals competes with

Company Long-Term Debts haleon.com HLN|KVUE - Company Long-Term Debt|Company Long-Term Loans and Borrowings VRNA (Verona Pharma PLC)|Jyong Biotech Corp (MENS) - Company Long-Term Debt|Company Long-Term Liabilities Ligand Corp|AMRX (Amneal Pharmaceuticals) - Company Long-Term Debts|Company Long-Term Debts perrigo.com|Company Long-Term Liabilities ALVO (Alvotech SA)|LQDA (Liquidia Corp) - Company Long-Term Loans and Borrowings|Company Long-Term Debt Galapagos Genomics GLPG|ANI Pharmaceuticals Corp (ANIP) - Long-Term Debt|MNKD: Company Long-Term Liabilities|amphastar.com - Amount of Long-Term Liabilities|PCRX: Company Long-Term Debts|ARS Pharmaceuticals Inc - Company Long-Term Loans and Borrowings|TBPH (Theravance) - Company Long-Term Debts|Long-Term Debt Aquestive Corp AQST|Company Long-Term Debt scPharmaceuticals Inc. (SCPH)|TECX (tectonictx.com) - Company Long-Term Loans and Borrowings|China SXT Pharmaceuticals, Inc. - Company Long-Term Liabilities|Amount of Long-Term Liabilities EPRX (Eupraxia Pharmaceuticals, Inc.)|BHST - Company Long-Term Debt|Long-Term Debt Invizyne|oramed.com (ORMP) - Company Long-Term Debt|Company Long-Term Indebtedness ENTX|HYFT (MindWalk Holdings Inc.) - Company Long-Term Debts|ABVC BioPharma Inc. (ABVC) - Long-Term Debt Volume|Company Long-Term Liabilities CPIX (Cumberland Pharma)|Quantum BioPharma Corp - Company Long-Term Indebtedness|FibroGen, Inc. - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings TELO|RANI - Company Long-Term Debt|Long-Term Liabilities SNYR|RLYB: Company Long-Term Debts|Lexaria Bioscience Corp. - Company Long-Term Loans and Borrowings|PULM (Pulmatrix, Inc.) - Company Long-Term Debts|Company Long-Term Debts Pheton|Company Long-Term Debt Aptorum Group Limited (APM)|LYRA (Lyra Therapeutics Inc.) - Company Long-Term Loans and Borrowings|Company Long-Term Debt Impact BioMedical Inc IBO|TNFA - Company Long-Term Liabilities|cbdMD Corp - Company Long-Term Debts|PRFX - Company Long-Term Debts|CYTO: Company Long-Term Debts|Company Long-Term Liabilities Lipella Pharmaceuticals Inc|OPTN (Optinose) - Company Long-Term Debts|Long-Term Debt Pieris Pharma PIRS|Company Long-Term Liabilities PROC (Procaps Group S.A.)|Company Long-Term Debts petrospharma.com (PTPI)|Qilian International Holding - Company Long-Term Liabilities|Amount of Long-Term Liabilities SLRN (Acelyrin Inc.)|TFF Pharma - Company Long-Term Debts